GlassScriptPhysician profile
Phillip William Dickinson
NPI 1386737773
$3,018.76
in general payments reported to CMS, 2019-2025
8 companies · $830 in 2025
The $830 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $966 · 2021: $67.94 · 2022: $442 · 2023: $193 · 2024: $317 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $830 · Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $830.10 |
| Food and Beverage | $509.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $830.10 | 2025 | Amnioexcel |
| Heron Therapeutics, INC. | $812.50 | 2020 | |
| Davol INC. | $537.97 | 2020-2022 | |
| Acera Surgical, INC. | $316.64 | 2024 | Restrata Wound Matrix |
| Intuitive Surgical, INC. | $193.27 | 2023 | Da Vinci Surgical System |
| La Jolla Pharmaceutical Company | $172.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Covidien LP | $30.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Dickinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.